NEW: publication of the Mayo Clinic
& Beyond Verbal paper
Discovering vocal biomarkers associated
with Coronary Artery Disease
What are Vocal Biomarkers
#xMed2017 – Beyond Verbal & Mayo Clinic presenting Vocal Biomarkers
Working with leading research institutes around the world, Beyond Verbal is extracting vocal parameters in order to reveal vocal biomarkers – distinct voice features indicating various health conditions.
The ability to extract vocal biomarkers in a nonintrusive, continuous and passive manner has the potential to revolutionize conventional patient care. Beyond Verbal’s AI technology is set to improve traditional and remote healthcare services and create a novel, patient-centric approach. This paradigm shift will be achieved by gathering an additional layer of personal data which can support the tailoring of healthcare services to individual needs – a service which is challenging for all healthcare providers to deliver today.Download the white paper
Voice Research to Identify New Biomarkers
Coronary Artery Disease (CAD), Mayo Clinic first paper of its kind, globally, discovering vocal biomarkers associated with Coronary Artery Disease
Autism Spectrum Disorder (ASD) – Abnormal Speech Spectrum and Increased pitch variability in young autistic children
Parkinson’s Disease (PD) – Digital voice analysis in Parkinson’s disease Beyond Verbal is the first company to identify vocal biomarkers for physical health conditions as well as neurological disorders.